JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5026
Bankwell Financial Group
BWFG
$527M
| $121K | ﹤0.01% |
4,118
+1,033
| +33% | +$30.8K |
2017 Q4
20 quarters
|
|
|
TBIL
5027
F/m US Treasury 3 Month Bill Fund
TBIL
$7.44B
| $121K | ﹤0.01% |
+2,418
| New | +$121K |
2022 Q4
0 quarters
|
|
|
SPLK
5028
PUT
DELISTED
Splunk Inc
SPLK
| $121K | ﹤0.01% |
1,400
-100
| -7% | -$8.07K |
2020 Q4
8 quarters
|
|
|
ICVX
5029
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $121K | ﹤0.01% |
15,179
-540
| -3% | -$2.32K |
2021 Q3
5 quarters
|
|
5030
Caesarstone
CSTE
$101M
| $120K | ﹤0.01% |
21,133
+8,752
| +71% | +$65.4K |
2013 Q2
38 quarters
|
|
5031
Future Fuel
FF
$224M
| $120K | ﹤0.01% |
14,770
-4,481
| -23% | -$33.8K |
2013 Q2
38 quarters
|
|
|
NFYS
5032
DELISTED
Enphys Acquisition Corp.
NFYS
| $120K | ﹤0.01% |
12,000
-174,500
| -94% | -$1.72M |
2021 Q4
4 quarters
|
|
5033
Alto Ingredients
ALTO
$294M
| $119K | ﹤0.01% |
41,287
+1,479
| +4% | +$5.26K |
2021 Q1
7 quarters
|
|
5034
Concrete Pumping Holdings
BBCP
$495M
| $119K | ﹤0.01% |
20,315
+5,852
| +40% | +$38.9K |
2019 Q1
15 quarters
|
|
|
SRTA
5035
Strata Critical Medical Inc
SRTA
$426M
| $119K | ﹤0.01% |
33,247
-16,912
| -34% | -$72.3K |
2022 Q1
3 quarters
|
|
5036
First Trust Indxx NextG ETF
NXTG
$575M
| $119K | ﹤0.01% |
1,962
-627
| -24% | -$37.5K |
2021 Q3
5 quarters
|
|
5037
Preformed Line Products
PLPC
$2.03B
| $119K | ﹤0.01% |
1,434
+68
| +5% | +$5.61K |
2017 Q4
20 quarters
|
|
5038
Red Robin
RRGB
$152M
| $119K | ﹤0.01% |
21,307
-31,517
| -60% | -$235K |
2016 Q4
24 quarters
|
|
5039
X4 Pharmaceuticals
XFOR
$288M
| $119K | ﹤0.01% |
+3,987
| New | +$189K |
2022 Q4
0 quarters
|
|
|
GOEV
5040
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $119K | ﹤0.01% |
212
-85
| -29% | -$52.1K |
2021 Q2
6 quarters
|
|
5041
PUT
Datadog
DDOG
$99.3B
| $118K | ﹤0.01% |
+1,600
| New | +$125K |
2022 Q4
0 quarters
|
|
5042
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$1.98B
| $118K | ﹤0.01% |
3,258
+267
| +9% | +$9.7K |
2015 Q2
30 quarters
|
|
5043
Tilly's
TLYS
$141M
| $118K | ﹤0.01% |
12,970
+549
| +4% | +$4.82K |
2015 Q1
31 quarters
|
|
5044
Wheels Up
UP
$124M
| $118K | ﹤0.01% |
571
-838
| -59% | -$216K |
2021 Q3
5 quarters
|
|
5045
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.97B
| $117K | ﹤0.01% |
5,000
-3,732
| -43% | -$86.5K |
2022 Q2
2 quarters
|
|
5046
Pure Cycle
PCYO
$262M
| $117K | ﹤0.01% |
11,083
+425
| +4% | +$3.98K |
2017 Q4
20 quarters
|
|
5047
ProShares Ultra Silver
AGQ
$1.29B
| $116K | ﹤0.01% |
3,627
+1,549
| +75% | +$39.9K |
2022 Q2
2 quarters
|
|
|
LGHL
5048
Lion Group Holding
LGHL
$177K
| – | – |
0
| – | – |
2021 Q1
7 quarters
|
|
5049
iShares New York Muni Bond ETF
NYF
$1.53B
| $116K | ﹤0.01% |
2,205
-4,000
| -64% | -$206K |
2015 Q4
28 quarters
|
|
5050
VanEck Steel ETF
SLX
$162M
| $116K | ﹤0.01% |
2,008
+100
| +5% | +$5.68K |
2020 Q4
8 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.